Last reviewed · How we verify
NCT07165496
Text Messaging to Promote HIV Testing in Gay Men
NA trial testing Text message-based intervention in HIV Testing in 400 participants. Completed in 31 December 2015.
31 December 2015
Quick facts
| Lead sponsor | Universidad Peruana Cayetano Heredia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 400 |
| Start date | 1 April 2015 |
| Primary completion | 31 December 2015 |
| Estimated completion | 31 December 2015 |
| Sites | 1 location across Peru |
Drugs / interventions tested
- Text message-based intervention
Conditions studied
- HIV Testing — all drugs for HIV Testing →
Sponsor
Universidad Peruana Cayetano Heredia — full company profile →
Who can join
18 and older, male only, with HIV Testing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The rate of HIV and other sexually transmitted infections (STIs) remains high among Peruvian men who have sex with men (MSM), and new prevention programs should be developed to reach and provide sexual health services to more MSM. The Internet is a feasible medium both for recruiting participants and for implementing projects with MSM in Lima, Peru. Likewise, in Peru, mobile phones are promising tools for carrying out HIV-related interventions due to the high rate of mobile phone penetration. The Internet is a way to reach MSM who do not attend traditional health centers due to the stigma associated with being homosexual. Since mobile phones can be used to promote health, the investigators proposed to design, implement, and evaluate an intervention using text messages to promote HIV testing among Peruvian MSM recruited online. To achieve this objective, the investigators conducted a randomized controlled trial to assess the efficacy of a text message-based intervention to promote HIV testing among MSM in Lima recruited via the Internet.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07165496
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for HIV Testing
Currently open trials in the same condition.
- NCT07074899 — Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru · NA · active not recruiting
- NCT06785376 — P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biome · NA · recruiting
- NCT05384145 — Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Su · NA · recruiting
Other Universidad Peruana Cayetano Heredia trials
Trials by the same sponsor.
- NCT06367361 — One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis · Phase 2 · not yet recruiting
- NCT06989502 — Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries · NA · not yet recruiting
- NCT06565507 — Oxfendazole in Mild Parenchymal Brain Cysticercosis · Phase 2, PHASE3 · not yet recruiting
- NCT05981378 — Genomic Approaches to Dissect Human Host-pathogen Interactions in the Amazonian Rainforest · not yet recruiting
- NCT06500013 — WhatsApp Intervention to Assess the Effect of Messages in Adherence to Antiretrovirals in Young People With HIV in Peru · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07165496 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Peruana Cayetano Heredia
- Last refreshed: 24 November 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07165496.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing